Author's response: Understanding the natural progression in %FEV 1 decline in patients with cystic fibrosis: A longitudinal study: Understanding the natural progression in %FEV 1 decline in patients with cystic fibrosis: A longitudinal study

David Taylor-Robinson; Margaret Whitehead; Finn Diderichsen; Hanne Vebert Olesen; Tania Pressler; Rosalind Smyth; Peter Diggle

doi:10.1136/thoraxjnl-2012-202954

Author's response: Understanding the natural progression in %FEV 1 decline in patients with cystic fibrosis: A longitudinal study: Understanding the natural progression in %FEV 1 decline in patients with cystic fibrosis: A longitudinal study

David Taylor-Robinson
, Margaret Whitehead
, Finn Diderichsen
, Hanne Vebert Olesen
, Tania Pressler
, Rosalind Smyth
, Peter Diggle

University of Liverpool
University of Copenhagen
Aarhus University
University College London

Research output: Contribution to journal › Letter › peer-review

2 Citations (Scopus)

Original language	English
Pages (from-to)	294-295
Number of pages	2
Journal	Thorax
Volume	68
Issue number	3
DOIs	https://doi.org/10.1136/thoraxjnl-2012-202954
Publication status	Published - 1 Mar 2013
Externally published	Yes

Access to Document

10.1136/thoraxjnl-2012-202954

Cite this

Taylor-Robinson, D., Whitehead, M., Diderichsen, F., Olesen, H. V., Pressler, T., Smyth, R., & Diggle, P. (2013). Author's response: Understanding the natural progression in %FEV 1 decline in patients with cystic fibrosis: A longitudinal study: Understanding the natural progression in %FEV 1 decline in patients with cystic fibrosis: A longitudinal study. Thorax, 68(3), 294-295. https://doi.org/10.1136/thoraxjnl-2012-202954

@article{ef557381e98d4833b5dd9a5f92ac9afd,

title = "Author's response: Understanding the natural progression in \%FEV 1 decline in patients with cystic fibrosis: A longitudinal study: Understanding the natural progression in \%FEV 1 decline in patients with cystic fibrosis: A longitudinal study",

author = "David Taylor-Robinson and Margaret Whitehead and Finn Diderichsen and Olesen, \{Hanne Vebert\} and Tania Pressler and Rosalind Smyth and Peter Diggle",

year = "2013",

month = mar,

day = "1",

doi = "10.1136/thoraxjnl-2012-202954",

language = "English",

volume = "68",

pages = "294--295",

journal = "Thorax",

issn = "0040-6376",

publisher = "BMJ Publishing Group",

number = "3",

}

Taylor-Robinson, D, Whitehead, M, Diderichsen, F, Olesen, HV, Pressler, T, Smyth, R & Diggle, P 2013, 'Author's response: Understanding the natural progression in %FEV 1 decline in patients with cystic fibrosis: A longitudinal study: Understanding the natural progression in %FEV 1 decline in patients with cystic fibrosis: A longitudinal study', Thorax, vol. 68, no. 3, pp. 294-295. https://doi.org/10.1136/thoraxjnl-2012-202954

Author's response: Understanding the natural progression in %FEV 1 decline in patients with cystic fibrosis: A longitudinal study: Understanding the natural progression in %FEV 1 decline in patients with cystic fibrosis: A longitudinal study. / Taylor-Robinson, David; Whitehead, Margaret; Diderichsen, Finn et al.
In: Thorax, Vol. 68, No. 3, 01.03.2013, p. 294-295.

Research output: Contribution to journal › Letter › peer-review

TY - JOUR

T1 - Author's response: Understanding the natural progression in %FEV 1 decline in patients with cystic fibrosis: A longitudinal study: Understanding the natural progression in %FEV 1 decline in patients with cystic fibrosis: A longitudinal study

AU - Taylor-Robinson, David

AU - Whitehead, Margaret

AU - Diderichsen, Finn

AU - Olesen, Hanne Vebert

AU - Pressler, Tania

AU - Smyth, Rosalind

AU - Diggle, Peter

PY - 2013/3/1

Y1 - 2013/3/1

U2 - 10.1136/thoraxjnl-2012-202954

DO - 10.1136/thoraxjnl-2012-202954

M3 - Letter

SN - 0040-6376

VL - 68

SP - 294

EP - 295

JO - Thorax

JF - Thorax

IS - 3

ER -

Taylor-Robinson D, Whitehead M, Diderichsen F, Olesen HV, Pressler T, Smyth R et al. Author's response: Understanding the natural progression in %FEV 1 decline in patients with cystic fibrosis: A longitudinal study: Understanding the natural progression in %FEV 1 decline in patients with cystic fibrosis: A longitudinal study. Thorax. 2013 Mar 1;68(3):294-295. doi: 10.1136/thoraxjnl-2012-202954